Exploring the microbiome: Part 2// Bioinformatics and Data Sciences : From raw data to conclusions
Many nutritional or drug intervention strategies can modulate the microbiome. This topic highlighting the microbiome analysis will be splitted in two different webinars. In these sessions, experts from Biofortis will cover steps from sample collection to data analysis in the microbiome assessment.
As a pioneer in Microbiome expertise, and an expert CRO, Biofortis designed and conducted more than 100 pre-clinical and clinical protocols integrating a microbiome component.
In october, Françoise Le Vacon, CSO explained the microbiome with focus on new efficacy and toxicity endpoint in clinical studies.
In the second part of the “Exploring the microbiome” session, Diego Tomassi, PhD and Data Scientist, and Sébastien Leuillet, CTO in Biofortis describes the importance of bioinformatics and statistics on the evaluation and comprehension of microbiome, from raw data to interpretable results. Stéphane Deniau, Business Manager is the moderator of this session.
They have discussed:
– Bioinformatics tools: transforming raw microbiome sequencing data into usable clinical endpoints
– Improve the value of your clinical study with state-of-the-art methods from statistics and machine learning
If you miss the part 1, you can watch it here : The Microbiome: new efficacy and toxicity endpoint in clinical studies
